1. McConathy WJ, Alaupovic P. Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett 1973; 37: 178-182. 2. Drayna D, Fielding C, McClean J, et al. Cloning and expression of human apolipoprotein D cDNA. J Biol Chem 1986; 261: 16565-16569. 3. Francone OL, Gurakar A, Fielding C. Distribution and functions of lecitin: cholesterol acyltransferase and cholesterol ester transfer protein in plasma lipoproteins. J Biol Chem 1989; 264: 7066-7072. 4. Balbín M, Freije JMP, Fueyo A,et al. Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease. Biochem J 1990; 271: 803-807. 5. Sánchez LM, Vizoso F, Díez-Itza I, López-Otín C. Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res 1992; 52: 95-100. 6. Vizoso F, Sánchez LM, Díez-Itza I, et al. Factors affecting protein composition of breast secretions from non lactating women. Breast Cancer Res Treat 1992; 23: 251-258. 7. Díez-Itza I, Vizoso F, Merino AM, et al. Expression and prognostic significance of aoplipoprotein D in Breast cancer. Am J Pathol 1994; 144: 310-320. 8. Serra C, Vizoso F, Lamelas ML, et al. Expression and clinical significance of apolipoprotein D in male breast cancer. Br J Surg 1999; 86: 1190-1197. 9. Serra C, Vizoso F, Lamelas ML, et al. Comparative study of two androgen-induced markers (apolipoprotein D and pepsinogen C in female and male breast carcinomas). Int J Surg Invest 2000; 2: 183-192. 10. Aspirall JO, Bentel JM, Horsfall DJ, et al. Differential expression of apolipoprotein D and prostate specific antigen in benign and malignant prostate tissues. J Urol 1995; 154: 622-628. 11. Zhang SXD, Bentel JM, Ricciardelli C, et al. Immunolocalization of apolipoprotein D, androgen receptor and prostate specific antigen in early stage prostate cancers. J Urol 1998; 159: 548-554. 12. Rodríguez JC, Díaz M, González LO, et al. Apolipoprotein D expresión in benign and malignant prostate tissues. Int J Surg Invest 2000; 4: 310-326. 13. Vázquez J, González LO, Merino AM, Vizoso F. Expresión of apolipoprotein D In ovarian carcinomas and correlation with clinicopathologic parameters. Ginecology Oncology 2000; 76: 340-347. 14. Vázquez J, González LO, Lamelas ML, et al. Apolipoprotein D in endometrial carcinomas. Acta Obstet Ginecol Scand 2001; 80: 148-152. 15. Simard J, Dauvois S, Haagensen DE, et al. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Endocrinology 1990; 126: 3223-3231. 16. Simard J, Veilleux R, de Launoit Y, et al. Stimulation of apolipoprotein D secretion by steroid coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells. Cancer Res 1991; 51: 4336-4341. 17. Sugimoto K, Simard J, Haagensen DE, Labrie F. Inverse relationship between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells. J Steroid Biochem Molec Biol 1994; 51: 167-174. 18. Simard J, de Launoit Y, Haagensen DE, Labrie F. Additive stimulatory action of glicocorticoids and androgens on basal and estrogen-repressed apolipoprotein D messenger ribonucleic acid levels and secretion in human breast cancer cells. Endocrinology 1992; 130: 1115-1121. 19. Poulin R, Baker D, Labrie F. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat 1988; 12: 213. 20. Blais Y, Sugimoto K, Cariere M-C, et al. Potent stimulatory effect of interleukin-1alpha on lipoprotein D and gross cystic disease fluid protein-15 expression in buman breast-cancer cells. Int J Cancer 1994; 59: 400. 21. López-Boado YS, Díez-Itza I, Tolivia J, López-Otín C. Glucocorticoids and androgens up-regulate the Zn-alpha2-glycoprotein messenger RNA in human breast cancer cells. Breast Cancer Res Treat 1994b; 29: 247-258. 22. Lea JA. Binding properties of progesterone-binding cyst protein, PBCP. Steroids 1988; 52: 337-338. 23. Peitsch MC, Boguski MS. Is apolipoprotein D a mammalian bilin-binding protein? New Biol 1989; 2: 197-206. 24. Boyles JK, Notterpek LM, Anderson LJ. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. J Biol Chem 1990; 265: 17805-17815. 25. Morais Cabral JH, Atkins GL, Sánchez LM et al. Arachidonic acid binds to apolipoprotein D: implications for the protein’s function. FEBS Letters 1996; 366:53-56. 26. Patel RC, Lange D, McConathy WJ, Patel YC. Probing the structure of the ligand binding cavity of lipocalins by fluorescence spectroscopy. Prot Eng 1997; 10: 621-625. 27. Milne RW, Rassart E, Marcel YL. Molecular biology of apolipoprotein D. Curr Opin Lipidol 1993; 4: 100-106. 28. Zeng C, Spielman AI, Voels BR, et al. A human axillary odorant is carrier by apolipoprotein D. Proc Natl Acad Sci USA 1996; 6626-6630. 29. Haagensen DE, Stewart P, Dilley WG, Wells SA. Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture-modulation by steroid hormones. Breast Cancer Res Treat 1992; 23: 77-86. 30. Morvillo V, Luthy IA, Capuro MI, et al. Atypical androgen receptor in the human melanoma cell line IIB-MEL-J. Pigment Cell Res 1995; 8: 135-141. 31. López-Boado YS, Tolivia J, López-Otín C. Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentation in human breast cancer cells. J Biol Chem 1994a; 269: 26871-26878.
|